The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (10 analysts) rates it none, with a mean price target of $181.
WEX Inc.
WEX · the NYSE · USD · Market cap $6.5B · 6,600 employees
WEX Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-11
Screened 2026-09-11 · the tape above runs as of 23:00 UTC · 17 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
WEX Inc. holds its Accumulation at $191.52. Consolidating, no directional conviction, held for 4 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 4 days |
| Price at the screen | $191.52 |
| Valuation | 19.13 trailing · 9.03 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.83 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 33.74% | Below 33% | Interest-bearing debt is 33.7% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.65% | Below 33% | Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit. | Pass |
| Receivables | 29.64% | Below 49% | Money owed to the company is 29.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 17.0% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFleet payments platform shows thin growth at any price
Every time a haulage firm settles its fuel bill on the road, WEX sits in the middle taking a cut. The business clears solid returns, with return on equity at 30 percent and a 12 percent profit margin, yet revenue is expanding only 6 percent a year. That pace leaves little room for error even though the shares trade at 8.1 times forward earnings and sit 27 percent below our own fair value.
We pass. The 10 analysts covering the name carry a buy rating and a median target of just 168 dollars, barely above the current 164 dollar price. Without a clearer moat or faster top-line momentum the valuation gap offers no real margin of comfort once modest growth is priced in.
Currency moves, fuel-price swings and competition from larger card networks keep execution risk elevated. The ethical screen is clear, yet the numbers still do not justify ownership today. Analysis, not advice.
| Forward P/E | 9.0xcheap for a company growing this fast |
| Trailing P/E | 19.1xreasonably valued |
| EPS, trailing | 10.01 |
| EPS, forward | 21.20 |
| Revenue growth | +14.2%steady growth |
| Profit margin | 12.6%thin but positive margins |
| Return on equity | 30.2%an exceptional return on shareholder capital |
| FCF yield | 20.40% |
| Debt to equity | 3.98heavy leverage: higher risk if revenue softens |
| Current ratio | 1.05adequate liquidity, worth monitoring |
| Beta | 0.83steadier than the market |
| Short interest, float | 0.09% |
| 52-week range | 125.29 - 203.99 |
| Market cap | $6.5B |
| Employees | 6,600 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeWEX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 39.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (10 analysts) rates it none, with a mean price target of $181.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (10 analysts) rates it none, with a mean price target of $181.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $140.50 | -2.2% | · | $978 | -2.2% |
| 2 months | $159.29 | -13.8% | · | $862 | -13.8% |
| 3 months | $160.33 | -14.3% | · | $857 | -14.3% |
| 6 months | $154.69 | -11.2% | · | $888 | -11.2% |
| 1 year | $142.11 | -3.4% | · | $967 | -3.4% |
| 2 years | $181.20 | -24.2% | · | $758 | -24.2% |
| 3 years | $180.51 | -23.9% | · | $761 | -23.9% |
| 5 years | $205.67 | -33.2% | · | $668 | -33.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever WEX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.